-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Smoking Cessation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Smoking Cessation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Smoking Cessation Drug Details: Psilocybin is under investigation for...
-
Product Insights
Primary Sjogren's Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Primary Sjogren’s Syndrome Clinical Trial Report Overview A total of 67 primary sjogren’s syndrome clinical trials have been conducted as of July 2024. The primary sjogren’s syndrome clinical trial report provides a comprehensive understanding of the primary sjogren’s syndrome clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Mipasetamab Uzoptirine in Malignant Fibrous Histiocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mipasetamab Uzoptirine in Malignant Fibrous Histiocytoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mipasetamab Uzoptirine in Malignant Fibrous Histiocytoma Drug Details: ADCT-601(BGB-601)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Erenumab in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Erenumab in Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Erenumab in Pain Drug Details: Erenumab (Aimovig, Aerinex, Pasurta, Glaseeq) is a human...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Copanlisib Hydrochloride in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Copanlisib Hydrochloride in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Copanlisib Hydrochloride in Fallopian Tube Cancer Drug Details: Copanlisib dihydrochloride...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Ipilimumab Biosimilar in Metastatic Biliary Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ipilimumab Biosimilar in Metastatic Biliary Tract Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ipilimumab Biosimilar in Metastatic Biliary Tract Cancer Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Hymecromone in Primary Sclerosing Cholangitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hymecromone in Primary Sclerosing Cholangitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hymecromone in Primary Sclerosing Cholangitis Drug Details: Hymecromone is under development...
-
Product Insights
Bone Marrow Transplant Rejection - Drugs In Development, 2024
Empower your strategies with our Bone Marrow Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Bone marrow transplant rejection is a complication that can occur after a stem cell or bone marrow transplant. The newly transplanted donor cells attack the transplant recipient's body. Symptoms include chest pain, chills, drop in blood pressure, fever, flushing, funny taste in the mouth, headache, hives, nausea, pain, and shortness of breath. Treatment includes immunosuppressive drugs. The Bone Marrow Transplant...
-
Product Insights
Graft Versus Host Disease (GVHD) - Drugs In Development, 2024
Empower your strategies with our Graft Versus Host Disease (GVHD) – Drugs In Development, 2024 report and make more profitable business decisions. Graft-versus-host disease (GVHD) is a complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor cells attack the transplant recipient's body. Symptoms include abdominal pain or cramps; nausea, vomiting, and diarrhea; dry or irritated eyes; jaundice; shortness of breath; vaginal dryness; and weight loss. Treatment includes immunosuppressants. The Graft Versus Host...
-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) - Drugs In Development, 2024
Empower your strategies with our Plaque Psoriasis (Psoriasis Vulgaris) – Drugs In Development, 2024 report and make more profitable business decisions. Plaque psoriasis, also known as psoriasis vulgaris, is the most common form of psoriasis, a chronic skin condition characterized by the rapid buildup of skin cells. It results from an overactive immune system, causing skin cells to accumulate on the surface, forming thick, scaly, and often itchy patches or plaques. These patches can vary in size and typically have a...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.